Skip to search formSkip to main contentSkip to account menu

Quetiapine fumarate

Known as: Fumarate, Quetiapine, Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt), Quetiapine Fumarate [Chemical/Ingredient] 
The fumarate salt form of quetiapine, a dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity… 
National Institutes of Health

Related topics

Related topics

22 relations
Adrenergic alpha-Antagonists [MoA]Autistic DisorderBipolar DisorderBlood Coagulation Disorders

Broader (2)

Antipsychotic Agentsquetiapine

Narrower (2)

ICI 204,636Seroquel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Electrochemical studies for the determination of quetiapine fumarate and olanzapine antipsychotic drugs.
PURPOSE Cyclic voltammetry and differential pulse voltammetry were used to explore the diffusion behavior of two antipsychotic… 
2012
2012
Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
Background: Bipolar I disorder (BPD I) is a recurrent illness that affects 1%of the US population and constitutes a large… 
2011
2011
Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Review
2010
Review
2010
Quetiapine XR: Current status for the treatment of major depressive disorder
2010
2010
Safety and tolerability of once‐daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double‐blind, placebo‐controlled studies
Extended release quetiapine fumarate (quetiapine XR) is a new formulation that allows once‐daily dosing and a titration regimen… 
2008
2008
Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia*
ABSTRACT Objective: To evaluate the clinical benefit, efficacy and tolerability of switching patients experiencing suboptimal… 
2008
2008
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia
This double-blind, double-dummy study (D1444C00146) evaluated the efficacy and safety of switching patients with clinically… 
2008
2008
Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
In the process for the preparation of quetiapine fumarate (1), six unknown impurities and one known impurity (intermediate) were… 
2006
2006
Acute Respiratory Failure with a Single Dose of Quetiapine Fumarate
Objective: To report a case of acute respiratory failure after a single dose of quetiapine fumarate in an elderly patient with a… 
2000
2000
Atypical antipsychotic effects of quetiapine fumarate in animal models.
AIM To evaluate the effect of quetiapine fumarate in animal models of schizophrenia and its possibility to induce extrapyramidal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)